Concepedia

L. S. Lin

LS

Statistics

Publications

3

Citations

152

H-Index

3

Active since

2004

Affiliations

Research International (United States)(Current)

University of California, Los Angeles

L. S. Lin is an author at Research International (United States) specializing in oncology, breast cancer, and cancer therapeutics.

Top concepts

Publications per year

2004–2011

3

Publications

3

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction

Z.A. Wainberg, L. S. Lin, Brian DiCarlo et al. · British Journal of Cancer · 2011 · 83 citations · Full text

Final Results of a Phase II Trial Evaluating Trastuzumab and Bevacizumab as First Line Treatment of HER2-Amplified Advanced Breast Cancer.

Sara A. Hurvitz, Mark D. Pegram, L. S. Lin et al. · Cancer Research · 2009 · 54 citations

, , +12

Targeting ErbB receptor interactions: A phase I trial of trastuzumab and erlotinib in metastatic HER2+ Breast Cancer

Carolyn D. Britten, Mark D. Pegram, Philip Rosen et al. · Journal of Clinical Oncology · 2004 · 15 citations

, , +15

1–3 of 3